Peptides for inducing cytotoxic t-lymphocyte responses to...

Details Peptides for inducing cytotoxic t-lymphocyte responses to... Peptides for inducing cytotoxic t-lymphocyte responses to...

C - Chemistry, Metallurgy

07

K

C07K 14/02 (2006.01) A61K 39/29 (2006.01) A61K 39/295 (2006.01) A61K 39/385 (2006.01) A61K 39/39 (2006.01) C07K 7/08 (2006.01) C07K 19/00 (2006.01) C12Q 1/70 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2115927

Peptides are used to define epitopes that stimulate HLA-restricted cytotoxic T lymphocyte activity against hepatitis B virus antigens. The peptides are derived from regions of HBV nucleocapsid, envelope, polymerase and the transcriptional transactivor X protein, and are particularly useful in treating or preventing HBV infection, including methods for stimulating the immune response of chronically infected individuals to respond to HBV antigens. Pharmaceutical compositions and hepatitis B vaccines which comprise the peptides and physiologically acceptable carriers can be employed in conjunction with other HBV vaccines to provide more effective immunity against the disease. Methods for identifying individuals who are particularly susceptible to deve-loping chronic HBV infection and who can be targeted for treatment by the CTL peptides are also provided.

Affiliated with

Also associated with

Rating

Peptides for inducing cytotoxic t-lymphocyte responses to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides for inducing cytotoxic t-lymphocyte responses to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for inducing cytotoxic t-lymphocyte responses to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1423840